BACKGROUND: The chemical instability of antiangiogenic fumagillin, combined with its poor retention during intravascular transit, requires an innovative solution for clinical translation. We hypothesized that an Sn-2 lipase-labile fumagillin prodrug, in combination with a contact-facilitated drug delivery mechanism, could be used to address these problems. METHODS: α(v)β(3)-targeted and nontargeted nanoparticles with and without fumagillin in the prodrug or native forms were evaluated in vitro and in vivo in the Matrigel™ (BD Biosciences, CA, USA) plug model of angiogenesis in mice. RESULTS: In vitro experiments demonstrated that the new fumagillin prodrug decreased viability at least as efficacious as the parent compound, on an equimolar basis. In the Matrigel mouse angiogenesis model, α(v)β(3)-fumagillin prodrug decreased angiogenesis as measured by MRI (3T), while the neovasculature was unaffected with the control nanoparticles. CONCLUSION: The present approach resolved the previously intractable problems of drug instability and premature release in transit to target sites.
BACKGROUND: The chemical instability of antiangiogenic fumagillin, combined with its poor retention during intravascular transit, requires an innovative solution for clinical translation. We hypothesized that an Sn-2lipase-labile fumagillin prodrug, in combination with a contact-facilitated drug delivery mechanism, could be used to address these problems. METHODS: α(v)β(3)-targeted and nontargeted nanoparticles with and without fumagillin in the prodrug or native forms were evaluated in vitro and in vivo in the Matrigel™ (BD Biosciences, CA, USA) plug model of angiogenesis in mice. RESULTS: In vitro experiments demonstrated that the new fumagillin prodrug decreased viability at least as efficacious as the parent compound, on an equimolar basis. In the Matrigel mouse angiogenesis model, α(v)β(3)-fumagillin prodrug decreased angiogenesis as measured by MRI (3T), while the neovasculature was unaffected with the control nanoparticles. CONCLUSION: The present approach resolved the previously intractable problems of drug instability and premature release in transit to target sites.
Authors: Hui-Fang Zhou; Grace Hu; Samuel A Wickline; Gregory M Lanza; Christine T N Pham Journal: Nanomedicine (Lond) Date: 2010-09 Impact factor: 5.307
Authors: S M Arfin; R L Kendall; L Hall; L H Weaver; A E Stewart; B W Matthews; R A Bradshaw Journal: Proc Natl Acad Sci U S A Date: 1995-08-15 Impact factor: 11.205
Authors: Alison K Esser; Anne H Schmieder; Michael H Ross; Jingyu Xiang; Xinming Su; Grace Cui; Huiying Zhang; Xiaoxia Yang; John S Allen; Todd Williams; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Katherine N Weilbaecher Journal: Nanomedicine Date: 2015-10-27 Impact factor: 5.307
Authors: Elizabeth M Wagner; John Jenkins; Anne Schmieder; Lindsey Eldridge; Qiong Zhang; Aigul Moldobaeva; Huiying Zhang; John S Allen; Xiaoxia Yang; Wayne Mitzner; Jochen Keupp; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza Journal: Angiogenesis Date: 2014-08-23 Impact factor: 9.596
Authors: Dipanjan Pan; Benjamin Kim; Grace Hu; Deepti Sood Gupta; Angana Senpan; Xiaoxia Yang; Anne Schmieder; Corban Swain; Samuel A Wickline; Michael H Tomasson; Gregory M Lanza Journal: Nanomedicine (Lond) Date: 2015-01 Impact factor: 5.307
Authors: Deepti Soodgupta; Dipanjan Pan; Grace Cui; Angana Senpan; Xiaoxia Yang; Lan Lu; Katherine N Weilbaecher; Edward V Prochownik; Gregory M Lanza; Michael H Tomasson Journal: Mol Cancer Ther Date: 2015-03-30 Impact factor: 6.261
Authors: Dipanjan Pan; Christine T N Pham; Katherine N Weilbaecher; Michael H Tomasson; Samuel A Wickline; Gregory M Lanza Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2015-08-21
Authors: Gregory M Lanza; John Jenkins; Anne H Schmieder; Aigul Moldobaeva; Grace Cui; Huiying Zhang; Xiaoxia Yang; Qiong Zhong; Jochen Keupp; Ismail Sergin; Krishna S Paranandi; Lindsey Eldridge; John S Allen; Todd Williams; Michael J Scott; Babak Razani; Elizabeth M Wagner Journal: Theranostics Date: 2017-01-01 Impact factor: 11.556
Authors: Hui-fang Zhou; Huimin Yan; Ying Hu; Luke E Springer; Xiaoxia Yang; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Christine T N Pham Journal: ACS Nano Date: 2014-06-24 Impact factor: 15.881